Biotech news for Monday, June 15, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Jazz Pharmaceuticals ( JAZZ ) traded lower in the premarket on Friday after announcing that its lung cancer therapy Zepzelca (lurbinectedin), developed with Spanish pharma company Pharma Mar ( PHMMF ), failed in a late-stage trial. The Phase 3 LAGOON trial tes…
Sakorn Sukkasemsakorn Rocket Pharmaceuticals ( RCKT ) on Friday disclosed more than $320M in cash, cash equivalents, and investments pro forma after completing the previously disclosed sale of its rare pediatric disease priority review voucher. In April, the c…
Nasdaq's latest reshuffle of the Nasdaq-100 ( NDX ) appears to favor some of the market's strongest performers, with the five incoming companies significantly outperforming the five names set to leave the index. Among the additions, Nebius Group ( NBIS ) leads…
JHVEPhoto/iStock Editorial via Getty Images Amgen ( AMGN ) has procured the services of the Duke Clinical Research Institute, a unit of the Duke School of Medicine, to re-evaluate data from its anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculi…
Gilnature/iStock via Getty Images Ascendis Pharma ( ASND ) said that new data from a phase 2 trial of its adult hypoparathyroidism treatment Yorvipath ( palopegteriparatide) indicate sustained efficacy over five years. The hormone replacement therapy led to a…
An expanded deal between Novartis ( NVS ) and privately held Orionis Biosciences for molecular glue drugs on Thursday boosted shares of Monte Rosa Therapeutics ( GLUE ), Kymera Therapeutics ( KYMR ), and Nurix Therapeutics ( NRIX ), which focus on similar drug…
Teerasak1988/iStock via Getty Images The US FDA has granted orphan drug designation to Alkermes' ( ALKS ) alixorexton for idiopathic hypersomnia. The oral orexin 2 receptor agonist is currently in phase 2. The condition is characterized by difficulty waking up…
georgeclerk Twist Bioscience ( TWST ) was the only Overweight-rated stock as Piper Sandler launched its coverage of the life sciences tools sector, recommending a wait-and-see approach until the group sees its next significant growth driver. Analyst David West…
Edesa Biotech ( Nasdaq: EDSA ) on Thursday said it entered into a securities purchase agreement for a private investment in public equity financing expected to raise approximately $3.5 million in gross proceeds. The clinical-stage biopharmaceutical company sai…
Propanc Biopharma ( PPCB ) approved a share repurchase program of up to $5M of its common stock. PPCB shares almost double, up 99.3% premarket. More on Propanc Biopharma, Inc. Historical earnings data for Propanc Biopharma, Inc. Financial information for Propa…